Envista Holdings Corp Stock Price, News & Analysis

Envista Holdings Corporation (NYSE: NVST) announced a four-year contract extension with Heartland Dental, the largest dental support organization in the U.S. This partnership solidifies Envista's role as a major supplier of dental products such as implants and imaging technology. Since their partnership began in 2016, Heartland Dental has accessed Envista's extensive product portfolio, enhancing care for over 1,800 supported dentists. This extension underscores Envista's commitment to quality and support within the dental industry.

Envista Holdings Corporation (NYSE: NVST) reported robust financial results for Q4 2020, with a net income of $108.4 million, translating to $0.64 per diluted share. Adjusted net income stood at $94.6 million, or $0.56 per diluted share. Notably, adjusted EBITDA grew by 23.1% to $150.8 million, and sales rose by 1.6% year-over-year to $732.3 million. Core sales increased by 3.4%, while operating cash flow also saw a rise of 3.4% to $193.4 million. The company repaid $472 million in bank term debt and aims for enhanced performance in 2021.

Envista Holdings Corporation (NYSE: NVST) will report its fourth quarter 2020 financial results on February 10, 2021, followed by a conference call at 2:00 PM PT. The call will be accessible via phone and webcast on Envista's website. The company, known for its extensive range of dental products, aims to help professionals enhance patient care. Envista partners with leading dental brands to address 90% of dentists' clinical needs, covering diagnostics and treatment options.

Envista Holdings Corporation (NYSE: NVST) will participate in the JP Morgan Healthcare Conference on January 11, 2021, at 4:30 PM ET. Investors can access the event via Envista's Investor Relations website. Envista is a leading global dental products company, offering a comprehensive portfolio that covers approximately 90% of dentists' clinical needs. Since separating from Danaher Corporation in 2019, Envista has established a strong market position through its commitment to innovation and customer-focused solutions. For more information, visit www.envistaco.com.

Envista Holdings Corporation (NYSE: NVST) reported its Q3 2020 financial results, showing a net income of $35.6 million, or $0.22 per share. Adjusted net income was $77.9 million, translating to $0.48 per diluted share. Sales fell by 2.9% year-over-year to $640.5 million, but sequential sales improved by 76.9% from Q2 2020. Adjusted EBITDA rose by 18.6% to $131.9 million. Free cash flow surged 70.3% to $134.9 million. The CEO highlighted significant recovery in the dental market and the impact of strategic initiatives on growth and margin.

Envista Holdings Corporation (NYSE: NVST) will announce third quarter financial results on October 29, 2020, followed by a conference call at 2:00 PM PT. The call will be accessible via the company's website, where both the earnings press release and an accompanying slide presentation will be available. Envista, which emerged as an independent company in 2019, serves the dental industry with a robust portfolio of brands and solutions. The company focuses on improving patient care through innovative dental products and technology.

Envista Holdings Corporation (NYSE: NVST) will participate in two upcoming healthcare conferences. The first is the Baird 2020 Global Healthcare Conference on September 9, 2020, where CEO Amir Aghdaei will present from 10:50 to 11:20 AM ET. The second event, the Morgan Stanley 18th Annual Global Healthcare Conference, is scheduled for September 16, 2020, with Aghdaei presenting from 4:15 to 4:45 PM ET. Investors can access these presentations on Envista's Investor Relations website.

Envista Holdings Corporation (NYSE: NVST) reported a net loss of $93.5 million, or $0.59 per share, for Q2 2020, marking a 49.2% decline in sales year-over-year to $362.0 million. Core sales dropped 46.2%, attributable to the COVID-19 pandemic impacts. Despite the losses, the company noted a sequential improvement in sales each month. Cost reduction measures exceeded $100 million, including workforce adjustments. Although no guidance for 2020 was provided due to uncertainties, management expressed optimism regarding recovery in the dental market and ongoing restructuring efforts.

Envista Holdings Corporation (NYSE: NVST) will announce its second-quarter 2020 financial results on July 30, 2020. The results will be discussed in a conference call starting at 2:00 PM PT, with a duration of approximately one hour. Interested parties can access the call by dialing 866-648-5306 (U.S.) or +1 602-563-8479 (international) with conference ID # 1571434. A replay will be available until August 13, 2020. Investors can view the earnings press release and related materials on the company's website.